One-fifth of cancer survivors, including those surviving prostate cancer, have current cancer-related chronic pain at least 2 years after their diagnosis, say researchers at the University of Michigan Health System, Ann Arbor.
One-fifth of cancer survivors, including those surviving prostate cancer, have current cancer-related chronic pain at least 2 years after their diagnosis, say researchers at the University of Michigan Health System, Ann Arbor.
A study by the Michigan team, published online in Cancer (Nov. 18, 2010), showed that more than 40% of patients surveyed had experienced pain since their diagnosis, and the pain experience was worse for African-Americans and women.
Adults of ages between 18 and 90 years who had prostate, colorectal, breast, lung cancer, or multiple myeloma at least 2 years to the start of the study were included. Participants were recruited from the Michigan State Cancer Center Registry.
Other findings included:
"All in all, the high prevalence of cancer and pain and now chronic cancer pain among these survivors, especially blacks and women, shows there’s more work to be done in improving the quality of care and research," said lead author Carmen R. Green, MD.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.